Humanized anti-CD4 antibody with immunosuppressive properties

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9758581
APP PUB NO 20140220008A1
SERIAL NO

14176485

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A humanized antibody derived from mouse monoclonal anti-CD4 antibody B-F5 is able to activate CD25+CD4+ regulatory T cells and is useful for preparing immunosuppressive compositions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OGEN GMBHWALDFRIEDSTRASSE 4 FRANKFURT AM MAIN 60528

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Jonuleit, Helmut Ginsheim-Gustavsburg, DE 12 180
Wijdenes, John Larnod, FR 13 402

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 12, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 12, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00